| 02.05 12:56 | dpa-AFX: BD Lifts FY24 Earnings View In Line Or Above Market Estimates; Stock Up In Pre-market |
| 02.05 12:36 | dpa-AFX: Becton, Dickinson and Company Q2 Profit Increases, beats estimates |
| 02.05 12:36 | dpa-AFX: *BD Q2 EPS $1.85 VS $1.53 PRIOR YEAR |
| 02.05 12:36 | dpa-AFX: *BD Q2 ADJ EPS $3.17 VS $2.86 PRIOR YEAR |
| 02.05 12:35 | dpa-AFX: *BD RAISES FULL-YEAR ADJ. EPS GUIDANCE AND AFFIRMS ORGANIC REVENUE GROWTH GUIDANCE |
| 02.05 12:32 | dpa-AFX: *BD Q2 REVENUE $5.0 BLN INCREASE OF 4.6% AS REPORTED, 4.7% CURRENCY-NEUTRAL AND 5.7% ORGANIC |
| 30.04 22:18 | dpa-AFX: *BECTON, DICKINSON AND COMPANY (BDX) DECLARES QUARTERLY DIVIDEND OF $ 0.95, RECORD DATE 6/10/2024 |
| 05.04 13:10 | dpa-AFX: BD Announces Global Commercial Release Of New BD FACSDiscover S8 Cell Sorters |
| 05.04 12:52 | dpa-AFX: *BD ANNOUNCES GLOBAL COMMERCIAL RELEASE OF NEW CELL SORTERS |
| 02.04 03:14 | dpa-AFX: AngioDynamics Settles All Patent Litigation With C.R. Bard |
| 27.02 12:55 | dpa-AFX: *BD SAYS EVP AND PRESIDENT OF LIFE SCIENCES SEGMENT DAVE HICKEY WILL RETIRE, EFFECTIVE JULY 1 |
| 21.02 12:48 | dpa-AFX: *BD PARTNERS WITH CAMTECH HEALTH TO INCREASE ACCESS TO CERVICAL CANCER SCREENING IN SINGAPORE |
| 01.02 13:03 | dpa-AFX: BD Q1 Adj. EPS Tops View, Lifts FY24 Outlook; Stock Up In Pre-market |
| 01.02 12:38 | dpa-AFX: *BD NOW PROJECTS FY ADJ EPS TO BE $12.82 TO $13.06 VS PRIOR ESTIMATION OF $12.70 TO $13.00 |
| 01.02 12:37 | dpa-AFX: *BD NOW EXPECTS FY REVENUES TO BE $20.2 BLN TO $20.4 BLN VS PRIOR OUTLOOK $20.1 BLN TO $20.3 BLN |
| 01.02 12:36 | dpa-AFX: *BD Q1 APPLICABLE NET INCOME $281 MLN VS $486 MLN PRIOR YEAR |
| 01.02 12:36 | dpa-AFX: *BD Q1 EPS $0.96 VS $1.70 PRIOR YEAR |
| 01.02 12:35 | dpa-AFX: *BD Q1 ADJ EPS $2.68 VS $2.98 PRIOR YEAR |
| 01.02 12:34 | dpa-AFX: Becton, Dickinson and Company Q1 Profit Decreases, but beats estimates |
| 01.02 12:32 | dpa-AFX: *BD Q1 REVENUE $4.7 BLN INCREASE OF 2.6% AS REPORTED, 1.6% CURRENCY-NEUTRAL AND 2.4% ORGANIC |
|
|
